Stock listing
Aroa Biosurgery Ltd
Selected listing: ARX · ASX · AUD · AU
Aroa Biosurgery Ltd (ASX:ARX), Health Technology. Latest release Oct 5, 2026: Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved…
- Ticker
- ASX:ARX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- ASX
- Currency
- AUD
About Aroa Biosurgery Ltd
Aroa Biosurgery Ltd is a public company traded on the Australian market under the ticker ARX. Aroa specializes in innovative biosurgery solutions, focusing on improving patient outcomes in surgical and wound care settings.
Latest news from Aroa Biosurgery Ltd
Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers
October 5, 2026
Symphony Significantly Improves DFU Healing
October 4, 2026
Peer-reviewed 411-patient study reports low infection rates with Myriad™ in complex soft tissue reconstruction
September 5, 2026
FY26 Full Year Results Presentation
May 25, 2026
ARX FY26 Preliminary Results
April 29, 2026